Net (Loss) Income Per Share (Tables)

9 Months Ended

12 Months Ended

Sep. 30, 2021

Dec. 31, 2020

Earnings Per Share [Abstract]

Schedule of Basic and Diluted Loss Per Share

Basic and diluted net (loss) income per share attributable to common stockholders was calculated as follows:

	Three Months Ended September 30,
	2021		2020
	(in thousands, except per share data)
Net (loss) income	$	(34,527)	$	12,758
Net (loss) income attributable to common stockholders	(34,527)		4,966
Basic weighted average number of common shares and common share equivalents outstanding (1)	414,572,706		88,863,244
Diluted weighted average number of common shares and common share equivalents outstanding (1)	414,572,706		248,133,335
Net (loss) income per share attributable to common stockholders—basic	$	(0.08)	$	0.06
Net (loss) income per share attributable to common stockholders—diluted	$	(0.08)	$	0.02

	Nine Months Ended September 30,
	2021		2020
	(in thousands, except per share data)
Net loss	$	(400,555)	$	(10,001)
Net loss attributable to common stockholders	(400,555)		(10,001)
Basic and diluted weighted average number of common shares and common share equivalents outstanding(1)	410,417,493		88,616,116
Net loss per share attributable to common stockholders—basic and diluted	$	(0.98)	$	(0.11)

__________________

(1)Prior period results have been adjusted to reflect the exchange of Legacy Clover's common stock for Clover Class B Common Stock at an exchange ratio of approximately 2.0681 in January 2021 as a result of the Business Combination. See Note 3 (Business Combination) for details.

Basic and diluted net loss per share attributable to common stockholders, after reverse capitalization, was calculated as follows(1):

	Year ended December 31,
	2020		2019
Net loss	$	(136,392)	$	(363,737)
Net loss attributable to common stockholders	(136,392)		(363,737)
Weighted average common shares outstanding—basic and diluted	88,691,582		87,829,419
Net loss per share attributable to common stockholders— basic and diluted	$	(1.54)	$	(4.14)

__________________

(1)Amounts in the above table have been adjusted to reflect the exchange of Legacy Clover’s common stock at an exchange ratio of approximately 2.0681 in January 2021 as a result of the application of reverse capitalization. See Note 3, “Reverse Capitalization,” for details.

Schedule of Antidilutive Securities Excluded from Diluted Net Loss Per Share

The Corporation excluded the following potential common shares, presented based on amounts outstanding at each period end, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect:

	Three Months Ended September 30,
	2021	2020
Options to purchase common stock (1)	33,477,833	5,183,834
RSUs	21,106,720	—
Warrants to purchase common stock (as converted to common stock) (1)	—	4,342,956
Warrants to purchase convertible preferred stock (as converted to common stock) (1)	—	2,618,770
Total anti-dilutive shares excluded from computation of earnings per share	54,584,553	12,145,560

	Nine Months Ended September 30,
	2021	2020
Options to purchase common stock (1)	33,477,833	37,296,034
RSUs	21,106,720	—
Convertible preferred stock (as converted to common stock) (1)	—	139,444,346
Warrants to purchase common stock (as converted to common stock) (1)	—	4,884,132
Warrants to purchase convertible preferred stock (as converted to common stock) (1)	—	2,618,770
Total anti-dilutive shares excluded from computation of earnings per share	54,584,553	184,243,282

__________________

(1)Prior period results have been adjusted to reflect the exchange of Legacy Clover's common stock for Clover Class B Common Stock at an exchange ratio of approximately 2.0681 in January 2021 as a result of the Business Combination. See Note 3 (Business Combination) for details.

The Corporation excluded the following potential common shares, presented based on amounts outstanding at each period end after reverse capitalization, from the computation of diluted net loss per share attributable to common stockholders for the periods indicated because including them would have had an anti-dilutive effect(1):

	Year ended December 31,
	2020	2019
Options to purchase common stock	36,557,759	24,344,848
Convertible preferred stock (as converted to common stock)	139,444,346	139,444,346
Warrants to purchase common stock (as converted to common stock)	7,502,902	4,884,132
Warrants to purchase convertible preferred stock (as converted to common stock)	—	2,618,770
	183,505,007	171,292,096

__________________

(1)Amounts in the above table have been adjusted to reflect the exchange of Legacy Clover’s common stock at an exchange ratio of approximately 2.0681 in January 2021 as a result of the application of reverse capitalization. See Note 3 (Reverse Capitalization) for details.